Cargando…

Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments

During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga-Medveczky, Zsófia, Kocsis, Dorottya, Naszlady, Márton Bese, Fónagy, Katalin, Erdő, Franciska
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619496/
https://www.ncbi.nlm.nih.gov/pubmed/34834264
http://dx.doi.org/10.3390/pharmaceutics13111852
_version_ 1784605006650933248
author Varga-Medveczky, Zsófia
Kocsis, Dorottya
Naszlady, Márton Bese
Fónagy, Katalin
Erdő, Franciska
author_facet Varga-Medveczky, Zsófia
Kocsis, Dorottya
Naszlady, Márton Bese
Fónagy, Katalin
Erdő, Franciska
author_sort Varga-Medveczky, Zsófia
collection PubMed
description During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes.
format Online
Article
Text
id pubmed-8619496
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86194962021-11-27 Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments Varga-Medveczky, Zsófia Kocsis, Dorottya Naszlady, Márton Bese Fónagy, Katalin Erdő, Franciska Pharmaceutics Review During the last decades, several technologies were developed for testing drug delivery through the dermal barrier. Investigation of drug penetration across the skin can be important in topical pharmaceutical formulations and also in cosmeto-science. The state-of- the-art in the field of skin diffusion measurements, different devices, and diffusion platforms used, are summarized in the introductory part of this review. Then the methodologies applied at Pázmány Péter Catholic University are shown in detail. The main testing platforms (Franz diffusion cells, skin-on-a-chip devices) and the major scientific projects (P-glycoprotein interaction in the skin; new skin equivalents for diffusion purposes) are also presented in one section. The main achievements of our research are briefly summarized: (1) new skin-on-a-chip microfluidic devices were validated as tools for drug penetration studies for the skin; (2) P-glycoprotein transport has an absorptive orientation in the skin; (3) skin samples cannot be used for transporter interaction studies after freezing and thawing; (4) penetration of hydrophilic model drugs is lower in aged than in young skin; (5) mechanical sensitization is needed for excised rodent and pig skins for drug absorption measurements. Our validated skin-on-a-chip platform is available for other research groups to use for testing and for utilizing it for different purposes. MDPI 2021-11-03 /pmc/articles/PMC8619496/ /pubmed/34834264 http://dx.doi.org/10.3390/pharmaceutics13111852 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Varga-Medveczky, Zsófia
Kocsis, Dorottya
Naszlady, Márton Bese
Fónagy, Katalin
Erdő, Franciska
Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_full Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_fullStr Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_full_unstemmed Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_short Skin-on-a-Chip Technology for Testing Transdermal Drug Delivery—Starting Points and Recent Developments
title_sort skin-on-a-chip technology for testing transdermal drug delivery—starting points and recent developments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619496/
https://www.ncbi.nlm.nih.gov/pubmed/34834264
http://dx.doi.org/10.3390/pharmaceutics13111852
work_keys_str_mv AT vargamedveczkyzsofia skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT kocsisdorottya skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT naszladymartonbese skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT fonagykatalin skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments
AT erdofranciska skinonachiptechnologyfortestingtransdermaldrugdeliverystartingpointsandrecentdevelopments